Iba Dosimetry America, Inc

Xcision Medical Systems LLC is a medical technology company dedicated to developing advanced stereotactic radiotherapy solutions specifically for early stage breast cancer treatment. Their flagship product, GammaPod, is the first and only system designed to provide a non-invasive, patient-friendly experience with a significantly shortened treatment course of 5 days or less. Receiving clearance from the FDA and the CE Mark in Europe, GammaPod aims to enhance the quality of cancer care while improving the lives of patients and their families. With a focus on innovative technology, Xcision strives to rethink breast cancer treatment and provide effective solutions for improving patient outcomes. Generated from the website

Iba Proton Therapy Inc, located in Herndon, VA, specializes in advanced proton therapy solutions for cancer treatment. The company is dedicated to innovation in medical imaging and radiation therapy, offering a range of services including dosimetry and integrated radiopharmacy. In addition to its focus on proton therapy, Iba Proton Therapy Inc provides industrial solutions and radioisotope services, showcasing its commitment to diverse applications in healthcare and beyond. The organization emphasizes sustainability and research through its Discovery Lab and various clinical content initiatives. Generated from the website

Altrix Medical, based in Centreville, VA, is a pioneering medical device company that is currently developing an innovative AED (Automated External Defibrillator) with advanced features such as wifi and bluetooth connectivity, real-time direction and coaching, ECG data transmission, and smartphone integration. With multiple languages supported and six patents awarded or pending, this cutting-edge device aims to provide the same life-saving energy as large AEDs in a portable and user-friendly format. As of now, the device is still under development and has not yet received FDA approval for sale in the United States. However, Altrix Medical has garnered significant recognition and support, including follow-on funding and a grant from the National Science Foundation, highlighting their commitment to advancing the field of medical technology and potentially revolutionizing emergency cardiac care.Generated from the website